The Friday Five – A Look at the J&J Vax
A few weeks ago, at the end of February,the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) for Johnson & Johnson’s single-dose COVID-19 vaccine. Immediately, plans to distribute the vaccine were rolled out and within days Americans were rolling up their sleeves to receive their shots. This week’s Friday Five takes a closer look at the newest COVID vaccine, how it compares to previously approved COVID vaccines, side effects and plans for future production.
Comparing the differences between COVID-19 vaccines
Mayo Clinic Insights: Dr. Swift discusses what you need to know about the new Johnson & Johnson COVID-19 vaccine. For more up to date information about #COVID19, visit https://t.co/ASk9YHSU73 pic.twitter.com/ML8wZWPZ4b
— Mayo Clinic (@MayoClinic) March 12, 2021
How effective is the Johnson & Johnson vaccine? Here’s what to know
NBC News reports that Johnson & Johnson’s single-dose shot, made in partnership with Janssen Pharmaceuticals, differs from the two others in several ways. It’s made differently, and, at first glance, it might appear to be less effective. But that doesn’t necessarily mean the Johnson & Johnson vaccine is inferior. Here’s why:
WHO adds Janssen vaccine to list of safe and effective emergency tools against COVID-19
The World Health Organization (WHO) listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen (Johnson & Johnson), for emergency use in all countries and for COVAX roll-out. The decision comes on the back of the European Medicines Agency (EMA) authorization, which was announced yesterday.
— World Health Organization (WHO) (@WHO) March 18, 2021
Merck to Help Produce Johnson & Johnson’s COVID-19 Vaccine
Merck recently (@Merck) announced a partnership with Johnson & Johnson to expand manufacturing capacity and supply of its COVID-19 vaccine. Under the Biomedical Advanced Research and Development Authority (BARDA) agreement, the company is adapting and making available some of their existing manufacturing sites to accelerate manufacturing efforts for the vaccine and enable more timely delivery and administration. Here are four reasons Merck is excited about the Johnson & Johnson partnership.
— Johnson & Johnson (@JNJNews) March 11, 2021